531 related articles for article (PubMed ID: 31862380)
1. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.
Lu Z; Li Y; Wang J; Che Y; Sun S; Huang J; Chen Z; He J
J Exp Clin Cancer Res; 2017 Apr; 36(1):54. PubMed ID: 28412955
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.
Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S
Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481
[TBL] [Abstract][Full Text] [Related]
4. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
[TBL] [Abstract][Full Text] [Related]
6. The long noncoding RNA NKILA protects against myocardial ischaemic injury by enhancing myocardin expression via suppressing the NF-κB signalling pathway.
Liu Q; Liu Z; Zhou LJ; Cui YL; Xu JM
Exp Cell Res; 2020 Feb; 387(2):111774. PubMed ID: 31838061
[TBL] [Abstract][Full Text] [Related]
7. NF-κB interaction long non-coding RNA inhibits migration, invasion and epithelial-mesenchymal transition of cervical cancer cells through inhibiting NF-κB signaling pathways.
Wang F; Jiang X; Wang P
Exp Ther Med; 2020 Aug; 20(2):1039-1047. PubMed ID: 32765657
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
Hu D; Zhong T; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-κB/Snail signaling pathway.
Zhang GD; Li Y; Liao GJ; Qiu HW
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4118-4125. PubMed ID: 31173281
[TBL] [Abstract][Full Text] [Related]
10. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
[TBL] [Abstract][Full Text] [Related]
11. Active fraction of Polyrhachis vicina Rogers (AFPR) suppressed breast cancer growth and progression via regulating EGR1/lncRNA-NKILA/NF-κB axis.
Li DM; Zhong M; Su QB; Song FM; Xie TG; He JH; Wei J; Lu GS; Hu XX; Wei GN
Biomed Pharmacother; 2020 Mar; 123():109616. PubMed ID: 31881485
[TBL] [Abstract][Full Text] [Related]
12. NF-κB/NKILA signaling modulates the anti-cancerous effects of EZH2 inhibition.
Duan S; Chan WK; Oman A; Basile DP; Alvira CM; Buxton ILO; Iosef C
J Cell Mol Med; 2019 Sep; 23(9):6182-6192. PubMed ID: 31282094
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NKILA regulates expression of HSP90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line.
Tibatan MA; Önay Uçar E
Mol Biol Rep; 2021 May; 48(5):4563-4571. PubMed ID: 34125329
[TBL] [Abstract][Full Text] [Related]
14. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
15. The reduced lncRNA NKILA inhibited proliferation and promoted apoptosis of chondrocytes via miR-145/SP1/NF-κB signaling in human osteoarthritis.
Xue H; Yu P; Wang WZ; Niu YY; Li X
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):535-548. PubMed ID: 32016955
[TBL] [Abstract][Full Text] [Related]
16. TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.
Lu Z; Chen Z; Li Y; Wang J; Zhang Z; Che Y; Huang J; Sun S; Mao S; Lei Y; Gao Y; He J
J Mol Med (Berl); 2018 Apr; 96(3-4):301-313. PubMed ID: 29379981
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA NKILA weakens TNF-α-induced inflammation of MRC-5 cells by miR-21 up-regulation.
Wang D; Zhang J; Sun Y; Lv N; Sun J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):498-505. PubMed ID: 32013579
[No Abstract] [Full Text] [Related]
18. Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling.
Yu X; Tang W; Yang Y; Tang L; Dai R; Pu B; Feng C; Xia J
Chem Biol Interact; 2018 Apr; 285():48-58. PubMed ID: 29481769
[TBL] [Abstract][Full Text] [Related]
19. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-3 affects vascular endothelial function and is regulated by angiotensin II.
Zhang C; Yu C; Li W; Zhu Y; Ye Y; Wang Z; Lin Z
Microvasc Res; 2020 Nov; 132():104043. PubMed ID: 32707048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
